Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Alere Inc    ALR   US01449J1051

ALERE INC (ALR)

3
Delayed Quote. Delayed Nyse - 04/24 04:02:01 pm
49.97 USD   -0.08%
04/06 ALERE : Reports Employment Inducement Awards Pursuant to NYSE Rule 3..
04/02 ALERE : Receives FDA Clearance for Alere(TM) i Strep A Rapid Molecul..
03/30DJCredits & Debits
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Alere Inc : Alere Inc. Schedules Conference Call for 8:30 a.m. ET February 8, 2012 to Discuss Fourth Quarter 2011 Results

02/01/2012 | 03:20pm US/Eastern

WALTHAM, Mass., Feb. 1, 2012 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced that it will release its fourth quarter 2011 earnings on Wednesday, February 8, 2012. The Company will also host a conference call beginning at 8:30 a.m. (Eastern Time) on that date to discuss these results and other corporate matters. During the conference call, the Company will discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously.

The conference call may be accessed by dialing (800) 860-2442 (domestic) or (412) 858-4600 (international) and asking for Alere Inc. A webcast of the call can also be accessed via the Alere website at www.alere.com/investors, or directly through the following link: http://www.videonewswire.com/event.

A replay will be available approximately four hours after the conclusion of the call and will remain available for a period of seven days following the call. The replay may be accessed by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international) and entering replay code 10009812. The replay will also be available via online webcast at http://www.videonewswire.com/event or via the Alere website at www.alere.com/investors for a period of 60 days following the call.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere enables individuals to take charge of improving their health and quality of life at home. Alere's global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, toxicology and women's health. Alere is headquartered in Waltham, Massachusetts.

For additional information on Alere, please visit www.alere.com.

SOURCE Alere Inc.

React to this article
Latest news on ALERE INC
04/09 ALERE : Posts Employment Inducement Awards Pursuant to NYSE Rule 303A.08
04/08 ALERE : Receives FDA Clearance for Alere™ i Strep A Rapid Molecular Test
04/06 ALERE : Reports Employment Inducement Awards Pursuant to NYSE Rule 303A.08
04/02 ALERE : Receives FDA Clearance for Alere(TM) i Strep A Rapid Molecular Test
03/30DJCredits & Debits
03/30 ALERE : Applauds President’s National Action Plan to Combat Antibiotic-Res..
03/30 ALERE : Applauds President's National Action Plan to Combat Antibiotic-Resistant..
03/23 ALERE : to Appoint Veteran Finance Executive, James F. Hinrichs, EVP and Chief F..
03/23 ALERE : Change in Directors or Principal Officers (form 8-K)
03/23 ALERE : to Appoint Veteran Finance Executive, James F. Hinrichs, EVP and Chief F..
Dynamic quotes  
ON
| OFF